In the genomic series reported by the DKFZ (German Cancer Research Group), among 118 samples with mRNA expression data, 58 samples (49.2%) had a mean MCOLN2 mRNA expression z score compared to all samples above 0, and 60 samples (50.8%) had a mean MCOLN2 mRNA expression z score compared to all samples of 0 or below (Table 2). Here, MCOLN2 is linked to cancer.